Historical perspective and recent progress in cardiac ion channelopathies research and clinical practice in Hong Kong

被引:0
作者
Keith Sai Kit Leung
Helen Huang
Cheuk To Chung
Danny Radford
Ishan Lakhani
Christien Ka Hou Li
Tommy Wai Kei Li
Simon Ranjithkumar
Rajesh Rajan
Leonardo Roever
Sebastian Garcia-Zamora
George Bazoukis
Tong Liu
机构
[1] Cardiovascular Analytics Group,Cardiac Electrophysiology Unit
[2] Kent and Medway Medical School,Sabah Al Ahmad Cardiac Center, Amiri Hospital
[3] Ministry of Health,Departamento de Pesquisa Clinica
[4] Universidade Federal de Uberlândia,Cardiac Intensive Care Unit, Department of Cardiology
[5] Delta Clinic,Department of Cardiology, Medical School
[6] University of Nicosia,Tianjin Key Laboratory of Ionic
[7] Second Hospital of Tianjin Medical University,Molecular Function of Cardiovascular Disease, Department of Cardiology, Tianjin Institute of Cardiology
[8] Aston University Medical School,Faculty of Health and Life Sciences
[9] Royal College of Surgeons in Ireland,Faculty of Medicine and Health Sciences
关键词
Ion channelopathies; Brugada syndrome; Catecholaminergic polymorphic ventricular tachycardia; Long QT syndrome; Sudden cardiac death; Risk stratification; Machine learning;
D O I
10.1186/s42444-023-00092-4
中图分类号
学科分类号
摘要
Cardiac ion channelopathies encompass a set of inherited or acquired conditions that are due to dysfunction in ion channels or their associated proteins, typically in the presence of structurally normal hearts. They are associated with the development of ventricular arrhythmias and sudden cardiac death. The aim of this review is to provide a historical perspective and recent advances in the research of the cardiac ion channelopathies, Brugada syndrome, long QT syndrome and catecholaminergic polymorphic ventricular tachycardia, in Hong Kong, China. In particular, recent works on the development of novel predictive models incorporating machine learning techniques to improve risk stratification are outlined. The availability of linked records of affected patients with good longitudinal data in the public sector, together with multidisciplinary collaborations, implies that ion channelopathy research efforts have advanced significantly.
引用
收藏
相关论文
共 138 条
[1]  
Tester DJ(2017)Evaluating the survivor or the relatives of those who do not survive: the role of genetic testing Cardiol Young 27 S19-S24
[2]  
Ackerman MJ(2009)Genetic testing for long-QT syndrome: distinguishing pathogenic mutations from benign variants Circulation 120 1752-1760
[3]  
Kapa S(2018)Role of genetic heart disease in sentinel sudden cardiac arrest survivors across the age spectrum Int J Cardiol 270 214-220
[4]  
Giudicessi JR(2018)Genetic basis of channelopathies and cardiomyopathies in Hong Kong Chinese patients: a 10-year regional laboratory experience Hong Kong Med J 24 340-349
[5]  
Ackerman MJ(2018)Next generation sequencing applications for cardiovascular disease Ann Med 50 91-109
[6]  
Mak CM(2019)Sudden arrhythmia death syndrome in young victims: a five-year retrospective review and two-year prospective molecular autopsy study by next-generation sequencing and clinical evaluation of their first-degree relatives Hong Kong Med J 25 21-29
[7]  
Kalayinia S(2010)A new approach to long QT syndrome mutation detection by Sequenom MassARRAY system Electrophoresis 31 1648-1655
[8]  
Mak CM(2017)Considerations when using next-generation sequencing for genetic diagnosis of long-QT syndrome in the clinical testing laboratory Clin Chim Acta 464 128-135
[9]  
Allegue C(2015)Genetic analysis of arrhythmogenic diseases in the era of NGS: the complexity of clinical decision-making in Brugada syndrome PLoS ONE 10 126-140
[10]  
Chae H(2013)An update on channelopathies: from mechanisms to management Circulation 127 418-425